| CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties M Vlaming, V Bilemjian, JÁ Freile, HJ Lourens, N van Rooij, G Huls, ... Scientific Reports 11 (1), 20499, 2021 | 26 | 2021 |
| The novel immune checkpoint GPR56 is expressed on tumor-infiltrating lymphocytes and selectively upregulated upon TCR signaling V Bilemjian, MR Vlaming, J Álvarez Freile, G Huls, M De Bruyn, E Bremer Cancers 14 (13), 3164, 2022 | 18 | 2022 |
| EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells V Melo, LC Nelemans, M Vlaming, HJ Lourens, VR Wiersma, V Bilemjian, ... Frontiers in Immunology 14, 1191866, 2023 | 5 | 2023 |
| Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival M Vlaming, V Bilemjian, JÁ Freile, V Melo, A Plat, G Huls, HW Nijman, ... Frontiers in Immunology 13, 1031746, 2022 | 5 | 2022 |
| Direct Functionalization of Polysaccharide‐Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies V Bilemjian, Y Lin, W Wan, G Egri, G Huls, T Heinze, E Bremer, M Gericke, ... ChemBioChem 25 (5), e202300828, 2024 | 2 | 2024 |
| Exploring novel immune checkpoints and targeted delivery strategies for ovarian cancer therapy V Bilemjian | | 2024 |
| 13P Tumor-infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival V Bilemjian Immuno-Oncology and Technology 16, 2022 | | 2022 |
| Tumor Infiltrating CD8/CD103/TIM-3-Expressing Lymphocytes In Epithelial Ovarian Cancer Co-Express CXCL13 And Associate With Improved Survival V Bilemjian Exploring novel immune checkpoints and targeted delivery strategies for …, 2022 | | 2022 |
| Supplementary Material EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells V Melo, LC Nelemans, M Vlaming, HJ Lourens, V Wiersma, V Bilemjian, ... | | |
